Get started
Tilray Brands, Inc.Tilray Brands, Inc.Tilray Brands, Inc.

Tilray Brands, Inc.

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsBondsETFs

Trade ideas

TLRY - Long Term Fibonacci Bottom ?This week (Wednesday) TLRY hits the long term 1:1.618 Fibonacci Time Extension taking the 3 most significant pivots. In addition it is also drifting within the 1:1.618 Golden Window for Trend Based Extension taking the wave 1 and 2 pivots from the 2021 top. This is high Fibonacci confluence that the bottom may be in or near and that the next bull market could be soon! Be aware that this is a high risk stock, but high risk is also high yield if you get it right. Not advice.
NASDAQ:TLRYLong
by dRends35
94
Massive bull run is imminent The big boys will try to push it down as close as possible to $1.50. If you look at the volume profile to the left you'll see some gaps at around $1.63 and $1.60, then there's also the POC at around $1.57. We have an unclosed gap slightly below the railroad tracks candle formation and it looks like the big boys are trying hard to fill it. Then there's a massive imbalance between $2.63 - $2.93 which will get taken out in the near future, on top of that MACD is hist is showing bullish divergence. Once the last dip to the downside is complete we'll see a massive rip to the upside. 2024 will be the year of cannabis stocks. That's your last chance to buy cheap weed stocks like TLRY.
NASDAQ:TLRYLong
by MoneyForNothingAndPipsForFree
7
TLRY's Green Revolution Cannabis Stocks on the NYSEAs of the most recent data, the S&P 500, which represents the performance of 500 of the largest companies listed on stock exchanges in the United States, is trading at an impressive level. The index has been on a bullish trend, consistently reaching new all-time highs in recent months. This upward trajectory can be attributed to a combination of factors, including strong corporate earnings, optimism surrounding economic recovery, and accommodative monetary policies from central banks. Investors' appetite for risk remains robust, and as long as these favorable conditions persist, the S&P 500's bullish trend is likely to continue, attracting both institutional and retail investors.
NASDAQ:TLRYLong
by DEXWireNews
2
TLRY Tilray Brands Options Ahead of EarningsIf you haven`t bought TLRY here: Then analyzing the options chain and the chart patterns of TLRY Tilray Brands prior to the earnings report this week, I would consider purchasing the 2.50usd strike price Calls with an expiration date of 2024-3-15, for a premium of approximately $0.55. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward to read your opinion about it.
NASDAQ:TLRYLong
by TopgOptions
2
A new Crazy Rally could Happen!Forbes: a top official at the Department of Health and Human Services released one of the most consequential announcements ever made at the federal level concerning cannabis prohibition. The agency formally recommended that cannabis be moved from Schedule I of the Controlled Substances Act, a classification for drugs that have a high potential for abuse and no recognized medicinal value, to the much less restrictive Schedule III. Rescheduling marijuana could have a significant impact on the revenue of marijuana companies. Currently, marijuana is classified as a Schedule I controlled substance under the federal Controlled Substances Act (CSA), which means that it is considered to have a high potential for abuse and no accepted medical use. This classification makes it difficult for marijuana companies to access traditional banking services and to deduct ordinary business expenses from their taxes. If marijuana were to be rescheduled to a less restrictive schedule, such as Schedule III, it would no longer be considered a controlled substance and would be subject to fewer federal regulations. This would allow marijuana companies to access traditional banking services, deduct ordinary business expenses from their taxes, and potentially expand into new markets. According to a study by the Marijuana Policy Project, rescheduling marijuana to Schedule III could increase the revenue of marijuana companies by up to 40%. The study also found that rescheduling could create over 100,000 new jobs in the marijuana industry. Of course, there are also some potential downsides to rescheduling marijuana. For example, it could lead to increased federal regulation of the industry, which could raise costs for marijuana companies. Additionally, rescheduling could make it easier for minors to access marijuana, which is a concern for many public health experts. Overall, the impact of rescheduling marijuana on the revenue of marijuana companies is likely to be positive. However, there are also some potential downsides that should be considered. Here are some specific ways that rescheduling marijuana could affect the revenue of marijuana companies: * **Increased access to banking services:** Currently, marijuana companies are largely unable to access traditional banking services due to the fact that marijuana is still illegal under federal law. This makes it difficult for them to operate and to collect payments from customers. Rescheduling marijuana would allow them to access traditional banking services, which would make it easier for them to operate and to manage their finances. * **Deductibility of business expenses:** Currently, marijuana companies are not allowed to deduct ordinary business expenses from their taxes. This is because marijuana is still illegal under federal law. Rescheduling marijuana would allow them to deduct these expenses, which would reduce their tax liability and improve their bottom line. * **Expansion into new markets:** Currently, marijuana is only legal in a handful of states. Rescheduling marijuana could open up the possibility for marijuana companies to expand into new markets, such as those where medical marijuana is legal but recreational marijuana is not. This would create new opportunities for growth and revenue. Overall, rescheduling marijuana is likely to have a positive impact on the revenue of marijuana companies. However, there are also some potential downsides that should be considered. The 2021 Rally was wild..!
NASDAQ:TLRYLong
by Moshkelgosha
7
Tilray (TLRY:NASDAQ) Demonstrates Enhanced PerformanceTilray, a prominent player in the cannabis industry, has recently disclosed positive advancements in both financial and operational aspects. These developments not only indicate a promising trajectory towards profitability but also reflect the company's persistent efforts to establish a sustainable business model. Diversification Through Acquisition of Anheuser-Busch's Brands Tilray's strategic move to acquire eight beer and beverage brands from Anheuser-Busch holds significant implications for the company's U.S. beverage alcohol segment and its overall business diversification strategy. This acquisition not only expands Tilray's product portfolio but also augments its appeal in the market. Investment Outlook and Strategy Considering the current scenario, we recommend considering Tilray's stock as a potential investment opportunity. However, it's important to note that the company operates within a high-risk environment typical of the cannabis industry. Therefore, adopting a cautious approach is advisable. Investors might opt for dollar-cost averaging, a strategy that involves investing fixed amounts at regular intervals. Additionally, initiating the investment with a modest position could be a prudent approach to manage risk exposure effectively. In conclusion, Tilray's recent positive financial and operational updates, coupled with its strategic acquisition, position the company on a noteworthy trajectory. Investors should approach this opportunity with careful consideration, keeping in mind the inherent risks associated with the industry. This content is provided for general information purposes only and is not to be taken as investment advice nor as a recommendation for any security, investment strategy or investment account.
NASDAQ:TLRYLong
by CapitalMarketsEliteGroup
TLRY is it still a buy? SHORTTLRY dropped from a Head & Shoulders in the winter into the lows in June and July with a lot of trading and accumulation as shown by the volume profile and its POC. Today TLRY took off for a big gainer of a day. But why and can it continue, The 5-minute chart shows plenty of volume support for today's move. The 4H chart shows a scorching rise into the third standard deviation line above the mean VWAP anchored into the earnings date two weeks ago which was a miss. Fundamentally, TLRY has been buying shares of BUD and other beer brewing or distribution companies. If i were an investor, I would be concerned. TLRY should focus on its core product and get good at making cash and not burning it. While the MACD is still bullish and the mass index indicator not yet triggering a reversal, I see a drop happening from the pop. Fundamentally TLRY does not deserve the level of enthusiasm that it received. The EFT MJ had a big uptrend for the day then printed a bearish engulfing candle on the close as traders took their profits off the table. In consideration of all of this, I think TLRY is a very safe short trade. I will zoom into the 5 minute time frame and go short from a high pivot. expecting a 10-15% return for the remainder of the week as the flush or at least drop kicks in especially from inexperienced traders buying in while TRLY is running high without reason into the greatly overbought zone. I suppose it could pump from a short squeeze instead of leveling out and dropping, so my trade will be small and risk constrained. Is you have any alternative idea why this rose so much please let me know!
NASDAQ:TLRYShort
by AwesomeAvani
3